International Clinical Trial: A Study of C-CAR168 in Participants With Progressive Multiple Sclerosis

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07825389) titled 'A Study of C-CAR168 in Participants With Progressive Multiple Sclerosis' on Sept. 8.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: AbelZeta Inc.

Condition: Multiple Sclerosis

Intervention: Drug: C-CAR168

Recruitment Status: Not recruiting

Phase: Phase 1/Phase 2

Date of First Enrollment: February 2027

Target Sample Size: 119

To know more, visit https://clinicaltrials.gov/study/NCT07825389

Published by HT Digital Content Services with permission from Health Daily Digest....